Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 760-765

  Lindel, Katja ^a,b   de Villiers, Ethel Michele ^a   Burri, Philipp ^b   Studer, Ueli ^b   Altermatt, Hans J ^c   Greiner, Richard H ^b   Gruber, Guenther ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c Pathology Laenggasse   (Switzerland)

Author keywords

Cervical cancer; E2 gene; Human papillomavirus; Radiation

Indexed keywords

BIOPSY; RADIATION; RADIOTHERAPY; STATISTICAL METHODS; TUMORS; VIRUSES;

CERVICAL CANCER; E2 GENES; HUMAN PAPILLOMAVIRUS; LOCAL PROGRESSION-FREE SURVIVAL (LPFS);

GENES;

GLYCOPROTEIN E2; GLYCOPROTEIN E2A; GLYCOPROTEIN E2B; GLYCOPROTEIN E2C; PARAFFIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPISOME; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OVERALL SURVIVAL; PRIORITY JOURNAL; SAMPLE; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VIRUS GENE; VIRUS INFECTION;

DNA PRIMERS; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 33646897664     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.023     Document Type: Article

References (44)

1. Spandidos D.A., Dokianakis D.N., Kallergi G., et al. Molecular basis of gynecological cancer. Ann N Y Acad Sci 900 (2000) 56-64
2. zur Hausen H. Papillomaviruses causing cancer. Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92 (2000) 690-698
3. Harima Y., Sawada S., Nagata K., et al. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 1345-1351
4. Ishikawa H., Mitsuhashi N., Sakurai H., et al. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with Stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 91 (2001) 80-89
5. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 (2000) 709-720
6. Lindel K., Beer K.T., Laissue J., et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx. A radiosensitive subgroup of head and neck carcinoma. Cancer 92 (2001) 805-813
7. Kalantari M., Karlsen F., Kristensen G., et al. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 17 (1998) 146-153
8. Vernon S.D., Unger E.R., Miller D.L., et al. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 74 (1997) 50-56
9. Ham J., Dostatni N., Gauthier J.M., et al. The papillomavirus E2 protein. A factor with many talents. Trends Biochem Sci 16 (1991) 440-444
10. Bouvard V., Storey A., Pim D., et al. Characterization of the human papillomavirus E2 protein. Evidence of trans-activation and trans-repression in cervical keratinocytes. Embo J 13 (1994) 5451-5459
11. Romanczuk H., Thierry F., and Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64 (1990) 2849-2859
12. Steger G., and Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 71 (1997) 50-58
13. Vance K.W., Campo M.S., and Morgan I.M. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J Biol Chem 274 (1999) 27839-27844
14. Desaintes C., Demeret C., Goyat S., et al. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. Embo J 16 (1997) 504-514
15. Goodwin E.C., Naeger L.K., Breiding D.E., et al. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J Virol 72 (1998) 3925-3934
16. Hwang E.S., Naeger L.K., and DiMaio D. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene 12 (1996) 795-803
17. Frattini M.G., Hurst S.D., Lim H.B., et al. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Embo J 16 (1997) 318-331
18. Wells S.I., Francis D.A., Karpova A.Y., et al. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. Embo J 19 (2000) 5762-5771
19. Lavergne D., and de Villiers E.M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 80 (1999) 681-684
20. Greer C.E., Peterson S.L., Kiviat N.B., et al. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 95 (1991) 117-124
21. Kleter B., van Doorn L.J., ter Schegget J., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153 (1998) 1731-1739
22. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (1995) 1057-1062
23. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
24. Alazawi W., Pett M., Strauss S., et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions. Associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer 91 (2004) 2063-2070
25. Duensing S., and Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62 (2002) 7075-7082
26. Duensing S., Lee L.Y., Duensing A., et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97 (2000) 10002-10007
27. Pett M.R., Alazawi W.O., Roberts I., et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 64 (2004) 1359-1368
28. Plug-DeMaggio A.W., Sundsvold T., Wurscher M.A., et al. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene 23 (2004) 3561-3571
29. Obermair A., Cheuk R., Horwood K., et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma. Effect on progression-free survival. Int J Gynecol Cancer 13 (2003) 633-6339
30. Winter III W.E., Maxwell G.L., Tian C., et al. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy. A Gynecol Oncol Group Study. Gynecol Oncol 94 (2004) 495-501
31. Butz K., Shahabeddin L., Geisen C., et al. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10 (1995) 927-936
32. Chen C.A., Chen T.M., Wu C.C., et al. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer. J Cancer Res Clin Oncol 120 (1994) 678-682
33. Hoppe-Seyler F., and Butz K. Molecular mechanisms of virus-induced carcinogenesis. The interaction of viral factors with cellular tumor suppressor proteins. J Mol Med 73 (1995) 529-538
34. Jiko K., Tsuda H., Sato S., et al. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int J Cancer 59 (1994) 601-606
35. Clarke A.R., Gledhill S., Hooper M.L., et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9 (1994) 1767-1773
36. Obata A., Eura M., Sasaki J., et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer 89 (2000) 187-193
37. Alazawi W., Pett M., Arch B., et al. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 62 (2002) 6959-6965
38. Johnston D., Hall H., DiLorenzo T.P., et al. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res 59 (1999) 968-974
39. Woodworth C.D., Gaiotti D., Michael E., et al. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes. Cancer Res 60 (2000) 4397-4402
40. Bonner J.A., Buchsbaum D.J., Russo S.M., et al. Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression. Int J Radiat Oncol Biol Phys 59 Suppl. 2 (2004) 2-10
41. Herbst R.S. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59 Suppl. 2 (2004) 21-26
42. Mathur S.P., Mathur R.S., Rust P.F., et al. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am J Reprod Immunol 46 (2001) 280-287
43. von Knebel Doeberitz M., Gissmann L., and zur Hausen H. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. Cancer Res 50 (1990) 3730-3736
44. de Jong A., van Poelgeest M.I.E., van der Hulst J.M., et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 64 (2004) 5449-5455